Literature DB >> 20658146

Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.

Takanori Kameda1, Kazuaki Nishijima, Noriyuki Unoki, Atsushi Sakamoto, Hisako Hayashi, Hideyasu Oh, Mihori Kita, Nagahisa Yoshimura.   

Abstract

PURPOSE: To evaluate the geographic pattern of central retinal sensitivity and its resolution shortly after intravitreal injection of triamcinolone acetonide (IVTA) for diabetic macular edema (DME).
METHODS: Twenty eyes of 20 patients who underwent IVTA for the treatment of DME were reviewed retrospectively. Early changes in best-corrected visual acuity (BCVA), central macular thickness (CMT), photoreceptor inner and outer segments (IS/OS) line and central retinal sensitivity were analyzed. Retinal sensitivity was measured at 40 points within the central 10 degrees of the macula with the Micro Perimeter 1 before treatment, and at 1 week and 1 month after IVTA.
RESULTS: Mean BCVA and CMT improved significantly at 1 week and 1 month after IVTA. Mean retinal sensitivity, however, showed no significant improvement at 1 week (P = 0.238), but did show significant improvement at 1 month (P = 0.0003). Mean retinal sensitivity of the points at the central 2 degrees, which was significantly lower than that at 6 and 10 degrees before treatment, showed improvement similar to those of 6 and 10 degrees after IVTA. Mean retinal sensitivity in the nasal quadrant of the macular area had the best sensitivity at all time points, and improved more than it did in the other quadrants. Mean retinal sensitivity in the central 2 degrees was better in the eyes with complete IS/OS line (P < 0.0001).
CONCLUSIONS: BCVA and CMT improved significantly after IVTA for DME. Retinal sensitivity also showed significant, albeit relatively slow, improvement. The nasal quadrant of the macular area showed more improvement than did any other quadrant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658146     DOI: 10.1007/s00417-010-1447-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.

Authors:  S Young; G Larkin; M Branley; S Lightman
Journal:  Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 4.207

2.  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

3.  Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

Authors:  J B Jonas; A Söfker
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

4.  Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.

Authors:  Florian K P Sutter; Judy M Simpson; Mark C Gillies
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

5.  Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema.

Authors:  Mandi D Conway; Christina Canakis; Charalampos Livir-Rallatos; Gholam A Peyman
Journal:  J Cataract Refract Surg       Date:  2003-01       Impact factor: 3.351

6.  Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.

Authors:  Michael S Ip; Justin L Gottlieb; Alon Kahana; Ingrid U Scott; Michael M Altaweel; Barbara A Blodi; Ronald E Gangnon; Carmen A Puliafito
Journal:  Arch Ophthalmol       Date:  2004-08

7.  Quantification of retinal capillary density and flow velocity in patients with essential hypertension.

Authors:  S Wolf; O Arend; K Schulte; T H Ittel; M Reim
Journal:  Hypertension       Date:  1994-04       Impact factor: 10.190

8.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Ingrid Kreissig; Antje Söfker; Robert F Degenring
Journal:  Arch Ophthalmol       Date:  2003-01

9.  Alterations in central retinal sensitivity after intravitreal triamcinolone injection for diffuse diabetic macular edema.

Authors:  Y Bardak; O Cekiç; U Sahin Tiğ; H Bardak
Journal:  Eur J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 2.597

10.  Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.

Authors:  Xinyuan Zhang; Shisan Bao; Donna Lai; Robert W Rapkins; Mark C Gillies
Journal:  Diabetes       Date:  2008-01-03       Impact factor: 9.461

View more
  2 in total

1.  Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.

Authors:  Fatih C Gundogan; Ahmet Tas; Salih Altun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

2.  [Influence of postoperative oral steroid treatment on retinal sensitivity in patients after macular surgery. A randomized, controlled, clinical trial].

Authors:  S Rezar; S Sacu; M Ritter; W Bühl; M Georgopoulos; U Schmidt-Erfurth; C Prünte
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.